Stocks
China Biologic Products Holdings (CBPO) EBITDA margin US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 41.9% | 39.3% | 36.3% | 43.3% | 46.1% | 46.1% | ||
| Changes by years, y/y, % | +1pp | -3pp | -3pp | +7pp | +3pp | +2.5% | |||
China Biologic Products Holdings. EBITDA margin, %
China Biologic Products Holdings. EBITDA margin, changes, pp
China Biologic Products Holdings (CBPO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2019Q4 | 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | LTM ? | |||
| EBITDA margin, % | ? | 27.9% | 49.6% | 48.4% | 45.5% | 39.4% | 46.1% | |
| Changes by years, y/y, % | -14pp | +4pp | +2pp | -4pp | +12pp | |||
| Changes by quarters, q/q, % | -22pp | +22pp | -1pp | -3pp | -6pp | |||
